Clincosm LogoSign in Get a demo

multiple myeloma

Showing NaN - NaN of 258
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Identify Barriers to Cellular Therapies for People With Plasma

Recruiting
  • Multiple Myeloma
  • Lecture on the role of cellular therapies in relapse/refractory multiple myeloma/RRMM
  • +5 more
  • Basking Ridge, New Jersey
  • +6 more
Nov 6, 2023

Multiple Myeloma, Monoclonal Gammopathy of Renal Significance Trial in United States (Cyclophosphamide, Bortezomib,

Recruiting
  • Multiple Myeloma
  • Monoclonal Gammopathy of Renal Significance
  • Basking Ridge, New Jersey
  • +6 more
Oct 16, 2023

Multiple Myeloma Trial in United States (Talquetamab)

Recruiting
  • Multiple Myeloma
  • Basking Ridge, New Jersey
  • +6 more
Sep 27, 2023

Multiple Myeloma Trial in Worldwide (idecabtagene vicleucel, Lenalidomide, Fludarabine)

Not yet recruiting
  • Multiple Myeloma
  • idecabtagene vicleucel
  • +3 more
  • Gilbert, Arizona
  • +107 more
Sep 26, 2023

Multiple Myeloma Trial in United States (IGM-2644)

Recruiting
  • Multiple Myeloma
  • Duarte, California
  • +4 more
Jun 9, 2023

Multiple Myeloma Trial in Worldwide (Iberdomide, Lenalidomide)

Not yet recruiting
  • Multiple Myeloma
  • Orange, California
  • +270 more
Apr 11, 2023

Multiple Myeloma, Osteoporosis Trial in United States (Romosozumab)

Recruiting
  • Multiple Myeloma
  • Osteoporosis
  • Basking Ridge, New Jersey
  • +6 more
Mar 7, 2023

Multiple Myeloma Trial in New York (Circadian Effective Lighting, Circadian Ineffective Lightning (CIL))

Recruiting
  • Multiple Myeloma
  • Circadian Effective Lighting
  • Circadian Ineffective Lightning (CIL)
  • New York, New York
  • +1 more
Feb 10, 2023

Multiple Myeloma Trial in Worldwide (Bortezomib, Dexamethasone, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • San Francisco, California
  • +152 more
Jan 27, 2023

Multiple Myeloma Trial in Worldwide (Teclistamab, Daratumumab, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Tucson, Arizona
  • +189 more
Jan 27, 2023

Multiple Myeloma Trial in Spain, United States (BB2121, CC-220, BMS-986405)

Recruiting
  • Multiple Myeloma
  • BB2121
  • +2 more
  • Birmingham, Alabama
  • +33 more
Jan 26, 2023

Multiple Myeloma Trial in United States (Lenalidomide, Daratumumab/rHuPH20)

Recruiting
  • Multiple Myeloma
  • Anchorage, Alaska
  • +698 more
Jan 24, 2023

Multiple Myeloma Trial in Worldwide (Selinexor, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Birmingham, Alabama
  • +60 more
Jan 24, 2023

Multiple Myeloma, AL Amyloidosis Trial in New York (Siltuximab, The M.D. Anderson Symptom Inventory (MDASI))

Active, not recruiting
  • Multiple Myeloma
  • AL Amyloidosis
  • Siltuximab
  • The M.D. Anderson Symptom Inventory (MDASI)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 23, 2023

Multiple Myeloma Trial in United States (Pomalidomide, stem cell, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Basking Ridge, New Jersey
  • +9 more
Jan 23, 2023

Taste Function In Multiple Myeloma Patients Undergoing

Active, not recruiting
  • Multiple Myeloma
  • Oral microbiota assessment
  • +3 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 23, 2023

Leukemia, Multiple Myeloma, Myelodysplastic Syndrome Trial in New York (biological, procedure, radiation, drug)

Active, not recruiting
  • Leukemia
  • +3 more
  • Palifermin
  • +6 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 23, 2023

Lymphoma, Multiple Myeloma, Acute Myeloid Leukemia Trial in United States (TTI-622, Azacitidine, Venetoclax)

Recruiting
  • Lymphoma
  • +3 more
  • Los Angeles, California
  • +36 more
Jan 23, 2023

Multiple Myeloma Trial in Worldwide (Cevostamab, Tocilizumab)

Recruiting
  • Multiple Myeloma
  • Birmingham, Alabama
  • +17 more
Jan 23, 2023

Multiple Myeloma Trial in New York (Iberdomide, Elotuzumab, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • New York, New York
    Icahn School of Medicine
Jan 20, 2023

Multiple Myeloma Trial in Worldwide (JNJ-68284528, Pomalidomide, Bortezomib)

Active, not recruiting
  • Multiple Myeloma
  • Birmingham, Alabama
  • +87 more
Jan 17, 2023

Multiple Myeloma Trial in Worldwide (Daratumumab, Lenalidomide, Dexamethasone)

Active, not recruiting
Has Results
  • Multiple Myeloma
  • Little Rock, Arkansas
  • +145 more
Jan 17, 2023

Multiple Myeloma Trial in Worldwide (Teclistamab, Daratumumab, Pomalidomide)

Active, not recruiting
  • Multiple Myeloma
  • Birmingham, Alabama
  • +26 more
Jan 17, 2023

Multiple Myeloma Trial in Worldwide (Daratumumab IV, Lenalidomide, Dexamethasone)

Active, not recruiting
Has Results
  • Multiple Myeloma
  • Daratumumab IV
  • +3 more
  • Birmingham, Alabama
  • +211 more
Jan 17, 2023

Multiple Myeloma Trial in France, Spain, United States (Daratumumab, Velcade, Pomalidomide)

Active, not recruiting
  • Multiple Myeloma
  • Duarte, California
  • +21 more
Jan 17, 2023